References
- Drakopanagiotakis F, Polychronopoulos V, Judson MA. Orga-nizing pneumonia. Am J Med Sci. 2008;335:34–9.
- Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rhematol Int. 2010.
- American Thoracic Society/European Respiratory Society Inter-national Multidisciplinary Consensus Classification of the Cryp-togenic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165(2):277–304.
- Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/ fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.
- Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their rela-tionship to prognosis. Histopathology. 2004;44(6):585–96.
- Yoshinouchi T, Ohtsuki Y, Fujita J, Yamadori I, Bandoh S, Ishida T, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int. 2005;26(2): 121–5.
- Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest. 1992;102(1 sup-pl):21S–5S.
- Komagata Y. COP associated with rheumatoid arthritis (in Jap-anese). Clin Rheumatol. 2008;20:71–5.
- Tokuda H. Cryptogenic organizing pneumonia in patients with collagen vascular disease-diagnosis and treatment (in Japanese). Rheumatology. 2009;42:172–82.
- Mori S, Cho I, Koga Y, Sugimoto M. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol. 2008;18(1):60–6.
- Lee YH, Kim YR, Ji JD, Shim JJ, Kong KH, Lee JH, et al. A case of BOOP developed during bucillamine treatment for rheuma-toid. Korean J Intern Med. 2001;16(1):36–9.
- Etanercept: proper use information, vol 9.
- Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol. 2009;36(5):898–906.
- Hagiwara K, Sato T, Takagi-Kobayashi S, Hasegawa S, Shigihara N, Akiyama 0. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol. 2007;34(5):1151–4.
- Toumadre A, Ledoux-Eberst J, Poujol D, Dubost JJ, Ristori JM, Soubrier M. Exacerbation of interstitial lung disease during eta-nercept therapy: two cases. Joint Bone Spine. 2008;75(2):215–8.